October 1st, 2015 [Fisher Healthcare Contracts Clean Collect]
The Stone Medical Corporation is excited to announce completion of a key distribution agreement with Fisher HealthCare for all Clean Collect products. Fisher HealthCare is a nationwide leader in the hospital and clinical lab market. "Working with Fisher reps, managers, and directors to help solve blood culture contamination issues has been excellent," reported CEO Ben Stone. Hospitals that order Clean Collect through Fisher will be eligible for the company's Matched Evaluation Program and new programs designed to promote long term improvement of contamination rates. Visit Fisher HealthCare at: www.fishersci.com/us/en/healthcare-products.html
April 15th, 2014 [Group Purchasing Organization Contracts Clean Collect]
The Stone Medical Corporation is pleased to announce signing of a contract with MAGNET Cooperative. MAGNET is one of the nation's largest GPOs representing over 1,100 hospitals and 9,500 healthcare facilities total. "We look forward to serving MAGNET members with Clean Collect now and new technologies in the future," commented CEO Ben Stone. Visit MAGNET at www.magnetgroup.com
August 21st, 2013 [Clean Collect Continues to Perform Well in US Hospitals ]
The Stone Medical Corporation has reported that hospitals using Clean Collect have achieved an overall average blood culture contamination rate less than 1% when Clean Collect is used for more than 85% of blood cultures. The reports include data from a Southern US hospital that reached a 0% rate of contamination from their previous average of 7.1% in the emergency department. "The new reports confirm that Clean Collect can help even at hectic emergency departments," commented CEO Ben Stone.
April 3rd, 2013 [New Clean Collect Kits for BacT/Alert Customers]
The Stone Medical Corporation has released Clean Collect CC-225 and CC-315 which are compatible with blood culture bottles from Biomerieux (BacT/Alert). The upgraded kits contain adaptors and material needed to collect blood cultures using the patented diversion method which prevents contamination. "The new Clean Collect kits will help us better serve those hospitals that need the special equipment in these kits to collect their blood cultures and reduce contamination," said Ben Stone, CEO of the company.
September 20th, 2012 [New Clean Collect Products for Emergency Departments]
The Stone Medical Corporation has released Clean Collect CC-220, a more advanced and complete version of the original Clean Collect kit. In addition, the company has also released CC-310, used by emergency departments to prevent contamination of blood cultures collected when starting IVs. "We have been striving to include feedback from as many doctors, nurses, and phlebotomists as possible when designing the new Clean Collect kits. As a result, the new products are much improved," commented Ben Stone. Visit www.cleancollect.com to learn more about the new Clean Collect kits.
May 15th, 2012 [Hospital Achieves 0% Rate of Blood Culture Contamination with Clean Collect]
The Stone Medical Corporation is pleased to announce that Clean Collect has reduced blood culture contamination rates at a Midwestern hospital to 0% for six consecutive months. Clean Collect uses a patented diversion method that has been clinically proven to reduce blood culture contamination rates. "This was an excellent performance by Clean Collect and the people using the kits," stated CEO Ben Stone.
November 16th, 2011 [New Business Advisor]
The Stone Medical Corporation welcomes Andy Shrago to the board of advisors. Andy is currently co-manager at Wisconsin Investment Partners and was previously the Senior Vice President of Sales and Marketing for Prodesse, Inc. The company was acquired by Gen-Probe in October of 2009 for $72 million. "Andy has many contacts at clinical labs throughout the US and is a great asset to our growing Advisory Board," commented Ben Stone. Learn more about us.
August 15th, 2011 [New Business Advisor]
The Stone Medical Corporation welcomes Jim Thomson to the board of advisors. Jim directed operations at John Deere Health, a HMO ranked first nationwide in customer satisfaction by Consumer Reports. After successful acquisition of John Deere Health, Jim founded Valley Health Services, providing healthcare insurance to communities throughout Iowa. "Jim's combined operational and entrepreneurial experience is exceptional. His advice covers many areas and has great value, " commented CEO Ben Stone. Learn more about us.
December 21st, 2010 [Diversion Method Prevents Blood Culture Contamination]
The Stone Medical Corporation announces the publication of research on Clean Collect's patented diversion method. The study included data from 7,876 hospital patients and demonstrated that the diversion method reduces blood culture contamination rates by 50% using a 0.5 - 2mL initial blood diversion. The diversion methods described in this study are claimed by patent 6,913,580 and are property of the Stone Medical Corporation. Contact us to receive a commercial reprint of the full study or click here to view an abstract of the study published in the Journal of Clinical Microbiology.
October 20th, 2010 [Phleb Pak]
The Stone Medical Corporation proudly presents the Phleb Pak, a closable phlebotomy case for use by phlebotomists, nurses, and other healthcare workers. Unlike conventional phlebotomy trays, the Phleb Pak resists spills that can be both time consuming and a serious safety risk for healthcare professionals. The Phleb Pak is more convenient and can increase productivity. The patent pending Phleb Pak can be seen at our new website www.phlebpak.com.
March 31st, 2010 [Clean Collect Website]
The Stone Medical Corporation is excited to announce the launch of our new product website www.cleancollect.com. The new site is fully dedicated to the Clean Collect Blood Collection System and features updated product information, research database, and live chat support. Regular visitors to www.stonemedcorp.com are greatly appreciated and encouraged to visit the new site.
November 12th, 2009 [New Industry Expert Advisor]
The Stone Medical Corporation welcomes Dr. Jon Lawrie, PhD as our industry expert advisor. Dr. Lawrie is well recognized as a leader in the field of biotechnology and has guided many emerging technologies through early stages to success. Dr. Lawrie's exceptional career includes roles as the founder, president, CEO, and director at companies ranging from startups to fortune 500 corporations. "Dr. Lawrie's industry credentials are hard to match and his advice has already helped shape the company's future," commented president Ben Stone.
October 15th, 2009 [Innovate Illinois 2009]
The Stone Medical Corporation is very proud to have advanced to the finals of the Innovate Illinois Competition. The company was presented to a panel of judges at the semifinals of the competition held in Champaign, IL. Video of the presentation will soon be available on the Innovate Illinois website. Twelve companies will compete for $80,000 in prize money and network with industry leaders, potential investors, and fellow entrepreneurs at the finals of the competition on November 10th, 2009 in Chicago, IL.
September 15th, 2009 [Finding Your Future: Science Career Investigation]
Ben Stone, president and CEO of the Stone Medical Corporation, is featured on the Finding Your Future website created by the Illinois Biotechnology Industry Organization (iBIO) Institute. The iBIO Institute is an organization dedicated to the development and retention of talented individuals in the Midwest, with a particular focus on the State of Illinois. The Finding Your Future program is one of many programs and projects undertaken by the iBIO Institute that have inspired many across the state and region.
July 1st, 2009 [Commercial Release of the Clean CollectTM Blood Collection System]
The Stone Medical Corporation is very excited to announce that the Clean Collect Blood Collection System is now available for purchase. Clean Collect reduces rates of blood culture contamination using diversion of initial blood flow (US Patent 6,913,580). By preventing blood culture contamination, Clean Collect saves medium to large hospitals between $3.2 million and $18.8 million each year. Clean Collect has the potential to save hospitals system-wide as much as $8.3 billion each year, a much needed cost reduction in the current era of rising healthcare costs. Hospitals may contact us directly to request product samples, information, arrange a meeting, or place orders for the Clean Collect Blood Collection System.
March 13th, 2009 [iBIO Entrepreneurial Center Matching Grant Award]
The Stone Medical Corporation is extremely pleased to accept a Matching Grant Award from the iBIO Entrepreneurial Center. The grant award is designed to match funds from the Company and will be applied to the final phase of clinical trials on the Clean Collect Blood Collection System scheduled to begin in September 2009. The final phase of clinical trials will be performed on the first generation commercial product, planned for release in the 3rd quarter of 2009.
February 25th, 2009 [New Business Advisor]
The Stone Medical Corporation welcomes Mark Achler as a business advisor to the Company. Mr. Achler is an exceptionally successful entrepreneur with a diverse background. He has founded and managed a wide variety of companies, foundations, and venture capital funds. "Mark is very experienced and highly intelligent. He has a proven track record of creating businesses and bringing them to prominence and profitability. We appreciate having his expertise available," commented president Ben Stone.
January 20th, 2009 [2009 Development & Commercialization Plan]
The Stone Medical Corporation has unveiled its 2009 plan for development and commercialization of the Clean Collect Blood Collection System. Based on progress in Phase I clinical trials, the plan calls for collection of data from 75,000 blood cultures by the year's end. "Our initial results are very promising and the continued research may provide absolute evidence of Clean Collect's ability to reduce blood culture contamination rates and hospital costs," commented president Ben Stone. While further research is conducted, the Stone Medical Corporation will also move forward with plans to prepare the product for commercial release in the 3rd quarter of 2009. Investors may request a copy or summary of this plan by contacting the principal office.
November 20th, 2008 [Illinois Fast Pitch Competition]
The Stone Medical Corporation is proud to accept the first place award for the second annual Illinois Fast Pitch Competition. The competition was held in Chicago, IL on November 18th with twenty companies competing for the award and a cash prize. Ben Stone, president of the Stone Medical Corporation, presented the company in a 3 minute presentation followed by a 2 minute Q&A session. Proceeds from the competition will be applied to the final payment for Phase I clinical trials on the Clean Collect Blood Collection System.
October 1st, 2008 [New Chief Scientific Advisor]
The Stone Medical Corporation welcomes Dr. Richard Albert, MD as a scientific advisor to the Company. Dr. Albert is the Chief of Medicine at the Denver Health Sciences Center, Vice Chairman of the University of Colorado Sciences Center, a tenured Professor at the University of Colorado Medical School, and an Adjunct Professor of Engineering and Computer Science at the University of Denver. Dr. Albert brings a wealth of clinical trials, medical, administrative, and general experience to the Company. "We look forward to continuing our work with Dr. Albert's expertise and knowledge added to our capabilities," comments Ben Stone, president of the Stone Medical Corporation. Click here for more information on the Company's current personnel.
August 1st, 2008 [Phase I Clinical Trials Begin]
The Stone Medical Corporation is pleased to announce the opening of the first phase of clinical trials on the Clean Collect Blood Collection System. Dr. Ronald Schifman is currently leading the study as principal investigator at the Veteran's Affairs (VA) Medical Center in Tucson, Arizona. Dr. Schifman's team includes an experienced clinical trials manager Mr. Tom Vincent, PA and two highly skilled technicians. The results of the first clinical study will help determine if Clean Collect is capable of reducing blood culture contamination rates and will provide background for full scale clinical trials.
Stone Medical Corporation
Stone Medical Corporation © 2007-2011 All Rights Reserved